Economic consequences of molecular profiling for metastatic solid tumors. Cost-effectiveness of pazopanib (PAZ) versus sunitinib (SUN) as first-line treatment of metastatic renal cell carcinoma (mRCC) ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, No. 14 (April 5, 2022), pp. 1-11 (11 pages) Coenzymes distribute a variety of chemical moieties throughout ...